Meanwhile, the combined therapy of anti-PD-1 antibody and Itga2-knockdown increased the populations of tumor-infiltrated CD45+CD8+ T-cells and CD45+CD4+ T-cells further but reduced that of myeloid-infiltrated CD11b+Gr1+ cells in tumors (Fig. 7f). Here, ITGAM is linked to neoplasm.